Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 65162-849

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 65162-849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

29516af3-figure-01 (Valsartan And Hydrochlorothiazide Tablets Usp 1)

A line graph showing the percentage of patients with systolic blood pressure (SBP) below 140 mmHg on the vertical axis versus baseline SBP values ranging from 140 to 180 mmHg on the horizontal axis. Four distinct lines represent treatment with Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, illustrating their comparative effects on SBP reduction.*

FDA Label Image

Fg (Valsartan And Hydrochlorothiazide Tablets Usp 10)

Label for Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/12.5 mg film-coated tablets by Amneal Pharmaceuticals LLC. The label indicates a quantity of 90 tablets and includes storage instructions, manufacturer details (Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad, India), distributor information (Amneal Pharmaceuticals LLC, Bridgewater, NJ), and a barcode. It highlights the strength, prescription status, and pharmacist dispensing instruction.*

FDA Label Image

Nb (Valsartan And Hydrochlorothiazide Tablets Usp 11)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/25 mg, film-coated oral tablets. The label shows the product name, strength, quantity of 90 tablets, and instructions for pharmacists to dispense with a patient information sheet. Manufactured by Amneal Pharmaceuticals Pvt. Ltd., India, and distributed by Amneal Pharmaceuticals LLC, New Jersey. Storage instructions and a barcode are also included.*

FDA Label Image

29516af3-figure-02 (Valsartan And Hydrochlorothiazide Tablets Usp 2)

A line graph showing the percentage of DBP-90 (mmHg) on the y-axis versus baseline DBP (mmHg) on the x-axis. The graph compares four groups: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, with distinct markers for each group.*

FDA Label Image

29516af3-figure-03 (Valsartan And Hydrochlorothiazide Tablets Usp 3)

A line graph comparing the percentage of patients achieving systolic blood pressure (SBP) below 130 mmHg across different baseline SBP values. The data series include Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, showing efficacy differences among the treatments.*

FDA Label Image

29516af3-figure-04 (Valsartan And Hydrochlorothiazide Tablets Usp 4)

A line graph depicting the percentage change in diastolic blood pressure (DBP) at 80 mmHg versus baseline DBP (mmHg). The graph compares four groups: Valsartan and Hydrochlorothiazide 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, with respective markers shown in the legend.*

FDA Label Image

Q (Valsartan And Hydrochlorothiazide Tablets Usp 5)

Chemical structure of Valsartan, one of the active ingredients in the combination drug Valsartan and Hydrochlorothiazide. The structure shows its molecular arrangement, including rings and functional groups relevant to its pharmacological activity.*

FDA Label Image

R (Valsartan And Hydrochlorothiazide Tablets Usp 6)

Chemical structure of the active ingredient Valsartan and Hydrochlorothiazide, showing molecular bonds and atoms including sulfur, chlorine, nitrogen, oxygen, and hydrogen.*

FDA Label Image

We (Valsartan And Hydrochlorothiazide Tablets Usp 7)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 80 mg/12.5 mg film-coated tablets by Amneal Pharmaceuticals LLC. The package contains 90 tablets with directions for pharmacist to dispense with patient information. Includes NDC 65162-845-09, storage instructions, manufacturer details, and dosage information.*

FDA Label Image

Nm (Valsartan And Hydrochlorothiazide Tablets Usp 8)

Label for Valsartan and Hydrochlorothiazide Tablets, USP, strength 160 mg/12.5 mg, film-coated oral tablets. The package contains 90 tablets. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. in India and distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes storage instructions and dosage details.*

FDA Label Image

Er (Valsartan And Hydrochlorothiazide Tablets Usp 9)

Label for Valsartan and Hydrochlorothiazide Tablets, USP with strength 160 mg/25 mg. The film-coated tablets come in a package of 90 tablets. The label lists Amneal Pharmaceuticals LLC as the distributor and Amneal Pharmaceuticals Pvt. Ltd. as the manufacturer. Storage instructions, dosage note, and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.